#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3030	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2747	253.6	0	.	n	.	0	C451T	SNP	451	451	C	1027	1027	T	336	T,C,A,G	224,86,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3030	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2747	253.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1760	1760	C	305	C,A,G	290,3,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3030	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2747	253.6	0	HET	.	.	.	C207T,A	.	207	207	C	783	783	C	233	C,T,A	157,49,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5734	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4354	319.2	0	.	n	.	0	T695C	SNP	695	695	T	1458	1458	C	291	C,T,A,G	281,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5734	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4354	319.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2734	2734	C	458	C,A	429,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5734	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4354	319.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2808	2808	A	456	A	444	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5734	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4354	319.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3360	3360	C	442	C,A,T,G	421,2,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5734	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4354	319.2	0	HET	.	.	.	A1638G,C	.	1638	1638	A	2401	2401	A	423	A,G,C	307,97,1	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	934	folP	855	855	100.0	folP.l6.c17.ctg.1	2072	106.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1327	1329	AGC	112;112;112	A;G,T;C	108;109,1;109	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1778	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4169	103.5	1	SNP	p	S91F	1	.	.	271	273	TTC	924	926	TTC	81;81;81	T;T;C,A	75;75;77,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1778	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4169	103.5	1	SNP	p	G95N	0	.	.	283	285	GGC	936	938	GGC	89;89;89	G,C;G,A;C	84,1;82,1;82	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1778	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4169	103.5	1	SNP	p	D95G	1	.	.	283	285	GGC	936	938	GGC	89;89;89	G,C;G,A;C	84,1;82,1;82	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1778	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4169	103.5	0	HET	.	.	.	G2377A,C,T	.	2377	2377	G	3030	3030	G	87	G,A,C,T	63,10,1,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	676	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2010	82.6	1	SNP	p	G45D	0	.	.	133	135	GGC	847	849	GGC	190;190;190	G;G;C,T	176;167;173,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	518	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1756	71.9	0	.	n	.	0	A197.	DEL	197	197	A	944	944	A	171	A	166	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3596	130.4	1	SNP	p	D86N	0	.	.	256	258	GAC	957	959	GAC	111;111;111	G,T;A,C;C	83,1;67,3;81	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3596	130.4	1	SNP	p	R87I	0	.	.	259	261	CGT	960	962	CGT	113;113;114	C;G;T,C	100;76;88,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3596	130.4	1	SNP	p	S87R	1	.	.	259	261	CGT	960	962	CGT	113;113;114	C;G;T,C	100;76;88,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3596	130.4	1	SNP	p	R87W	0	.	.	259	261	CGT	960	962	CGT	113;113;114	C;G;T,C	100;76;88,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1938	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3596	130.4	1	SNP	p	S88P	0	.	.	262	264	TCC	963	965	TCC	115;117;117	T,G;C,T,A;C	98,1;97,3,1;105	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1776	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2846	144.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1437	1439	GGC	131;131;131	G;G;C	108;114;100	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1516	1518	GCC	115;119;119	G;C,A;C,T	114;117,1;117,1	penA.34.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1519	1521	ATG	119;116;116	A,G;T;G	117,1;114;114	penA.34.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1531	1533	ACC	117;117;116	A,T,C,G;C;C	111,1,1,1;116;114	penA.34.002:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1531	1533	ACC	117;117;116	A,T,C,G;C;C	111,1,1,1;116;114	penA.34.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2032	2034	ACC	109;109;107	A;C;C	94;93;101	penA.34.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2086	2088	GCG	102;102;101	G;C,G,A;G,T,C	89;78,1,1;90,1,1	penA.34.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2086	2088	GCG	102;102;101	G;C,G,A;G,T,C	89;78,1,1;90,1,1	penA.34.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2209	2211	GGT	74;75;74	G;G,T,A;T,C,A	72;68,3,1;70,1,1	penA.34.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2218	2220	AGC	64;64;63	A,G;G,T;C,G	38,2;45,1;38,3	penA.34.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	958	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2689	83.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2236	2238	CCG	62;62;62	C,T,G;C,G,A;G,C,A	48,2,1;43,1,1;46,2,1	penA.34.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1456	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3897	90.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2056	2058	CCG	108;110;109	C,G,T;C,T,A;G,C,A	80,3,1;89,1,1;73,2,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	620	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2634	57.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	961	961	C	59	C,T	48,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	690	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2506	67.2	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1345	1347	AGA	119;120;120	A;G;A	118;118;119	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	690	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2506	67.2	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1366	1368	GGT	107;107;108	G;G;T	105;104;104	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	690	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2506	67.2	1	SNP	p	G120K	1	.	.	358	360	AAG	1075	1077	AAG	82;82;82	A,C;A,G,C;G,A	79,2;79,1,1;77,3	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	690	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2506	67.2	1	SNP	p	A121N	1	.	.	361	363	AAC	1078	1080	AAC	83;83;83	A,G;A;C,A	80,1;80;75,4	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	690	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2506	67.2	1	SNP	p	N121D	0	.	.	361	363	AAC	1078	1080	AAC	83;83;83	A,G;A;C,A	80,1;80;75,4	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2052	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5371	93.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	232	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1830	31.1	1	SNP	p	V57M	1	.	.	169	171	ATG	973	975	ATG	61;61;61	A;T;G	59;59;59	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
